Unbiased screen reveals ubiquilin-1 and -2 highly associated with huntingtin inclusions

Brain Research

Volumn 1524, Issue , 2013, Pages 62-73

  Rutherford, Nicola J ^a   Lewis, Jada ^a   Clippinger, Amy K ^a,b   Thomas, Michael A ^a   Adamson, Jennifer ^a   Cruz, Pedro E ^a   Cannon, Ashley ^c   Xu, Guilian ^a   Golde, Todd E ^a   Shaw, Gerry ^a   Borchelt, David R ^a   Giasson, Benoit I ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b NORTHERN KENTUCKY UNIVERSITY   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Huntington's disease; Inclusions; Transgenic mice; Ubiquilin

Indexed keywords

ALPHA SYNUCLEIN; HUNTINGTIN; POLYGLUTAMINE; PROTEIN; PROTEIN ANTIBODY; UBIQUILIN 1; UBIQUILIN 2; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; DEGENERATIVE DISEASE; DISEASE COURSE; GENE MUTATION; IMMUNOBLOTTING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; TRANSGENIC MOUSE;

HUNTINGTON'S DISEASE; INCLUSIONS; TRANSGENIC MICE; UBIQUILIN;

ANIMALS; BLOTTING, WESTERN; CARRIER PROTEINS; CELL CYCLE PROTEINS; DISEASE MODELS, ANIMAL; HUMANS; HUNTINGTON DISEASE; IMMUNOHISTOCHEMISTRY; INCLUSION BODIES; MICE; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; NEURODEGENERATIVE DISEASES; NUCLEAR PROTEINS;

MUS MUSCULUS;

EID: 84880325702     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2013.06.006     Document Type: Article

References (58)

1. Z. Ahmed, H. Sheng, Y.F. Xu, W.L. Lin, A.E. Innes, J. Gass, X. Yu, C.A. Wuertzer, H. Hou, S. Chiba, K. Yamanouchi, M. Leissring, L. Petrucelli, M. Nishihara, M.L. Hutton, E. McGowan, D.W. Dickson, and J. Lewis Accelerated lipofuscinosis and ubiquitination in granulin knockout mice suggest a role for progranulin in successful aging Am. J. Pathol. 177 2010 311 324
2. A. Al-Chalabi, A. Jones, C. Troakes, A. King, S. Al-Sarraj, and L.H. van den Berg The genetics and neuropathology of amyotrophic lateral sclerosis Acta Neuropathol. 124 2012 339 352
3. M.F. Beal Mitochondria, free radicals, and neurodegeneration Curr. Opin. Neurobiol. 6 1996 661 666
4. D.R. Borchelt, J. Davis, M. Fischer, M.K. Lee, H.H. Slunt, T. Ratovitsky, J. Regard, N.G. Copeland, N.A. Jenkins, S.S. Sisodia, and D.L. Price A vector for expressing foreign genes in the brains and hearts of transgenic mice Genet. Anal. 13 1996 159 163
5. J. Brettschneider, V.M. Van Deerlin, J.L. Robinson, L. Kwong, E.B. Lee, Y.O. Ali, N. Safren, M.J. Monteiro, J.B. Toledo, L. Elman, L. McCluskey, D.J. Irwin, M. Grossman, L. Molina-Porcel, V.M. Lee, and J.Q. Trojanowski Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion Acta Neuropathol. 123 2012 825 839
6. A. Cannon, B. Yang, J. Knight, I.M. Farnham, Y. Zhang, C.A. Wuertzer, S. D'Alton, W.L. Lin, M. Castanedes-Casey, L. Rousseau, B. Scott, M. Jurasic, J. Howard, X. Yu, R. Bailey, M.R. Sarkisian, D.W. Dickson, L. Petrucelli, and J. Lewis Neuronal sensitivity to TDP-43 overexpression is dependent on timing of induction Acta Neuropathol. 123 2012 807 823
7. M.A. Chishti, D.S. Yang, C. Janus, A.L. Phinney, P. Horne, J. Pearson, R. Strome, N. Zuker, J. Loukides, J. French, S. Turner, G. Lozza, M. Grilli, S. Kunicki, C. Morissette, J. Paquette, F. Gervais, C. Bergeron, P.E. Fraser, G.A. Carlson, P.S. George-Hyslop, and D. Westaway Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695 J. Biol. Chem. 276 2001 21562 21570
8. J.D. Davidson, B. Riley, E.N. Burright, L.A. Duvick, H.Y. Zoghbi, and H.T. Orr Identification and characterization of an ataxin-1-interacting protein: A1Up, a ubiquitin-like nuclear protein Hum. Mol. Genet. 9 2000 2305 2312
9. M. Dejesus-Hernandez, I.R. Mackenzie, B.F. Boeve, A.L. Boxer, M. Baker, N.J. Rutherford, A.M. Nicholson, N.A. Finch, H. Flynn, J. Adamson, N. Kouri, A. Wojtas, P. Sengdy, G.Y. Hsiung, A. Karydas, W.W. Seeley, K.A. Josephs, G. Coppola, D.H. Geschwind, Z.K. Wszolek, H. Feldman, D.S. Knopman, R.C. Petersen, B.L. Miller, D.W. Dickson, K.B. Boylan, N.R. Graff-Radford, and R. Rademakers Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS Neuron 72 2011 245 256
10. H.X. Deng, W. Chen, S.T. Hong, K.M. Boycott, G.H. Gorrie, N. Siddique, Y. Yang, F. Fecto, Y. Shi, H. Zhai, H. Jiang, M. Hirano, E. Rampersaud, G.H. Jansen, S. Donkervoort, E.H. Bigio, B.R. Brooks, K. Ajroud, R.L. Sufit, J.L. Haines, E. Mugnaini, M.A. Pericak-Vance, and T. Siddique Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia Nature 477 2011 211 215
11. H. Doi, K. Mitsui, M. Kurosawa, Y. Machida, Y. Kuroiwa, and N. Nukina Identification of ubiquitin-interacting proteins in purified polyglutamine aggregates FEBS Lett. 571 2004 171 176
12. A.A. El, E.S. Stieren, J.M. Barral, and D. Boehning Ubiquilin-1 regulates amyloid precursor protein maturation and degradation by stimulating K63-linked polyubiquitination of lysine 688 Proc. Nat. Acad. Sci. USA 109 2012 13416 13421
13. K.L. Emmer, E.A. Waxman, J.P. Covy, and B.I. Giasson E46K human alpha-synuclein transgenic mice develop Lewy-like and tau pathology associated with age-dependent, detrimental motor impairment J. Biol. Chem. 286 2011 35104 35118
14. D.G. Flood, A.G. Reaume, K.S. Dorfman, Y.G. Lin, D.M. Lang, S.P. Trusko, M.J. Savage, W.G. Annaert, B. De Strooper, R. Siman, and R.W. Scott FAD mutant PS-1 gene-targeted mice: increased A beta 42 and A beta deposition without APP overproduction Neurobiol. Aging 23 2002 335 348
15. M.S. Forman, J.Q. Trojanowski, and V.M. Lee Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs Nat. Med. 10 2004 1055 1063
16. F. Geser, M. Martinez-Lage, L.K. Kwong, V.M. Lee, and J.Q. Trojanowski Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases J. Neurol. 256 2009 1205 1214
17. B.I. Giasson, J.E. Duda, S.M. Quinn, B. Zhang, J.Q. Trojanoswki, and V.M.Y. Lee Neuronal α-synucleinopathy with severe movement disorder in mice expressing A53T human α-synuclein Neuron 34 2002 521 533
18. B.I. Giasson, H. Ischiropoulos, V.M.Y. Lee, and J.Q. Trojanoswki The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's diseases Free Radic. Biol. Med. 32 2002 1264 1275
19. M. Goedert, R. Jakes, and E. Vanmechelen Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205 Neurosci. Lett. 189 1995 167 169
20. M. Goedert, M.G. Spillantini, and S.W. Davies Filamentous nerve cell inclusions in neurodegenerative diseases Curr. Opin. Neurobiol. 8 1998 619 632
21. J. Hardy, and H. Orr The genetics of neurodegenerative diseases J. Neurochem. 97 2006 1690 1699
22. R. Heir, C. Ablasou, E. Dumontier, M. Elliott, C. Fagotto-Kaufmann, and F.K. Bedford The UBL domain of PLIC-1 regulates aggresome formation EMBO Rep. 7 2006 1252 1258
23. K. Hsiao, P. Chapman, S. Nilsen, C. Eckman, Y. Harigaya, S. Younkin, F. Yang, and G. Cole Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice Science 274 1996 99 102
24. J. Kim, L. Onstead, S. Randle, R. Price, L. Smithson, C. Zwizinski, D.W. Dickson, T. Golde, and E. McGowan Abeta40 inhibits amyloid deposition in vivo J. Neurosci. 27 2007 627 633
25. M.F. Kleijnen, A.H. Shih, P. Zhou, S. Kumar, R.E. Soccio, N.L. Kedersha, G. Gill, and P.M. Howley The hPLIC proteins may provide a link between the ubiquitination machinery and the proteasome Mol. Cell 6 2000 409 419
26. H.S. Ko, T. Uehara, K. Tsuruma, and Y. Nomura Ubiquilin interacts with ubiquitylated proteins and proteasome through its ubiquitin-associated and ubiquitin-like domains FEBS Lett. 566 2004 110 114
27. D.Y. Lee, and E.J. Brown Ubiquilins in the crosstalk among proteolytic pathways Biol. Chem. 393 2012 441 447
28. V.M. Lee, B.I. Giasson, and J.Q. Trojanowski More than just two peas in a pod: common amyloidogenic properties of tau and alpha-synuclein in neurodegenerative diseases Trends Neurosci. 27 2004 129 134
29. V.M.Y. Lee, M. Goedert, and J.Q. Trojanoswki Neurodegenerative tauopathies Annu. Rev. Neurosci. 24 2001 1121 1159
30. A.J. Lees, J. Hardy, and T. Revesz Parkinson's disease Lancet 373 2009 2055 2066
31. S. Lesage, and A. Brice Parkinson's disease: from monogenic forms to genetic susceptibility factors Hum. Mol. Genet. 18 2009 R48 R59
32. J. Lewis, E. McGowan, J. Rockwood, H. Melrose, P. Nacharaju, M. Van Slegtenhorst, K. Gwinn-Hardy, M.M. Paul, M. Baker, X. Yu, K. Duff, J. Hardy, A. Corral, W.L. Lin, S.H. Yen, D.W. Dickson, P. Davies, and M. Hutton Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein Nat. Genet. 25 2000 402 405
33. P.J. Lim, R. Danner, J. Liang, H. Doong, C. Harman, D. Srinivasan, C. Rothenberg, H. Wang, Y. Ye, S. Fang, and M.J. Monteiro Ubiquilin and p97/VCP bind erasin, forming a complex involved in ERAD J. Cell Biol. 187 2009 201 217
34. A.L. Mah, G. Perry, M.A. Smith, and M.J. Monteiro Identification of ubiquilin, a novel presenilin interactor that increases presenilin protein accumulation J. Cell Biol. 151 2000 847 862
35. I. Martin, V.L. Dawson, and T.M. Dawson Recent advances in the genetics of Parkinson's disease Annu. Rev. Genomics Hum. Genet. 12 2011 301 325
36. M. Mayford, M.E. Bach, Y.Y. Huang, L. Wang, R.D. Hawkins, and E.R. Kandel Control of memory formation through regulated expression of a CaMKII transgene Science 274 1996 1678 1683
37. F. Mori, K. Tanji, S. Odagiri, Y. Toyoshima, M. Yoshida, T. Ikeda, H. Sasaki, A. Kakita, H. Takahashi, and K. Wakabayashi Ubiquilin immunoreactivity in cytoplasmic and nuclear inclusions in synucleinopathies, polyglutamine diseases and intranuclear inclusion body disease Acta Neuropathol. 124 2012 149 151
38. L. Otvos Jr., L. Feiner, E. Lang, G.I. Szendrei, M. Goedert, and V.M.Y. Lee Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404 J. Neurosci. Res. 39 1994 669 673
39. C. Reitz, C. Brayne, and R. Mayeux Epidemiology of Alzheimer disease Nat. Rev. Neurol. 7 2011 137 152
40. C.A. Ross, and M.A. Poirier Protein aggregation and neurodegenerative disease Nat. Med. 10 Suppl 2004 S10 S17
41. C. Rothenberg, D. Srinivasan, L. Mah, S. Kaushik, C.M. Peterhoff, J. Ugolino, S. Fang, A.M. Cuervo, R.A. Nixon, and M.J. Monteiro Ubiquilin functions in autophagy and is degraded by chaperone-mediated autophagy Hum. Mol. Genet. 19 2010 3219 3232
42. D.M. Sampathu, B.I. Giasson, A.C. Pawlyk, J.Q. Trojanowski, and V.M. Lee Ubiquitination of alpha-synuclein is not required for formation of pathological inclusions in alpha-synucleinopathies Am. J. Pathol. 163 2003 91 100
43. K. Santacruz, J. Lewis, T. Spires, J. Paulson, L. Kotilinek, M. Ingelsson, A. Guimaraes, M. DeTure, M. Ramsden, E. McGowan, C. Forster, M. Yue, J. Orne, C. Janus, A. Mariash, M. Kuskowski, B. Hyman, M. Hutton, and K.H. Ashe Tau suppression in a neurodegenerative mouse model improves memory function Science 309 2005 476 481
44. D.J. Selkoe Alzheimer's disease: genes, proteins, and therapy Physiol. Rev. 81 2001 741 766
45. E. Sidransky, M.A. Nalls, J.O. Aasly, J. Aharon-Peretz, G. Annesi, E.R. Barbosa, A. Bar-Shira, D. Berg, J. Bras, A. Brice, C.M. Chen, L.N. Clark, C. Condroyer, E.V. De Marco, A. Durr, M.J. Eblan, S. Fahn, M.J. Farrer, H.C. Fung, Z. Gan-Or, T. Gasser, R. Gershoni-Baruch, N. Giladi, A. Griffith, T. Gurevich, C. Januario, P. Kropp, A.E. Lang, G.J. Lee-Chen, S. Lesage, K. Marder, I.F. Mata, A. Mirelman, J. Mitsui, I. Mizuta, G. Nicoletti, C. Oliveira, R. Ottman, A. Orr-Urtreger, L.V. Pereira, A. Quattrone, E. Rogaeva, A. Rolfs, H. Rosenbaum, R. Rozenberg, A. Samii, T. Samaddar, C. Schulte, M. Sharma, A. Singleton, M. Spitz, E.K. Tan, N. Tayebi, T. Toda, A.R. Troiano, S. Tsuji, M. Wittstock, T.G. Wolfsberg, Y.R. Wu, C.P. Zabetian, Y. Zhao, and S.G. Ziegler Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease N. Engl. J. Med. 361 2009 1651 1661
46. R. Siman, A.G. Reaume, M.J. Savage, S. Trusko, Y.G. Lin, R.W. Scott, and D.G. Flood Presenilin-1 P264L knock-in mutation: differential effects on abeta production, amyloid deposition, and neuronal vulnerability J. Neurosci. 20 2000 8717 8726
47. E.S. Stieren, A.A. El, Y. Xiao, E. Siller, M.L. Landsverk, A.F. Oberhauser, J.M. Barral, and D. Boehning Ubiquilin-1 is a molecular chaperone for the amyloid precursor protein J. Biol. Chem. 286 2011 35689 35698
48. J.P. Taylor, J. Hardy, and K.H. Fischbeck Toxic proteins in neurodegenerative disease Science 296 2002 1991 1995
49. A.T. Tebbenkamp, C. Green, G. Xu, E.M. Denovan-Wright, A.C. Rising, S.E. Fromholt, H.H. Brown, D. Swing, R.J. Mandel, L. Tessarollo, and D.R. Borchelt Transgenic mice expressing caspase-6-derived N-terminal fragments of mutant huntingtin develop neurologic abnormalities with predominant cytoplasmic inclusion pathology composed largely of a smaller proteolytic derivative Hum. Mol. Genet. 20 2011 2770 2782
50. K.J. Walters, M.F. Kleijnen, A.M. Goh, G. Wagner, and P.M. Howley Structural studies of the interaction between ubiquitin family proteins and proteasome subunit S5a Biochemistry 41 2002 1767 1777
51. H. Wang, P.J. Lim, C. Yin, M. Rieckher, B.E. Vogel, and M.J. Monteiro Suppression of polyglutamine-induced toxicity in cell and animal models of Huntington's disease by ubiquilin Hum. Mol. Genet. 15 2006 1025 1041
52. H. Wang, and M.J. Monteiro Ubiquilin interacts and enhance the degradation of expanded-polyglutamine proteins Biochem. Biophys. Res. Commun. 360 2007 423 427
53. J. Wang, G. Xu, V. Gonzales, M. Coonfield, D. Fromholt, N.G. Copeland, N.A. Jenkins, and D.R. Borchelt Fibrillar inclusions and motor neuron degeneration in transgenic mice expressing superoxide dismutase 1 with a disrupted copper-binding site Neurobiol. Dis. 10 2002 128 138
54. E.A. Waxman, and B.I. Giasson Molecular mechanisms of alpha-synuclein neurodegeneration Biochim. Biophys. Acta 1792 2008 616 624
55. E.A. Waxman, and B.I. Giasson Specificity and regulation of casein kinase-mediated phosphorylation of alpha-synuclein J. Neuropathol. Exp. Neurol. 67 2008 402 416
56. M. Westerlund, B. Hoffer, and L. Olson Parkinson's disease: exit toxins, enter genetics Prog. Neurobiol. 90 2010 146 156
57. B. Wolozin Regulated protein aggregation: stress granules and neurodegeneration Mol. Neurodegener. 7 2012 56
58. D. Zhang, S. Raasi, and D. Fushman Affinity makes the difference: nonselective interaction of the UBA domain of Ubiquilin-1 with monomeric ubiquitin and polyubiquitin chains J. Mol. Biol. 377 2008 162 180